Proactiveinvestors United Kingdom Motif Bio PLC https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom Motif Bio PLC RSS feed en Sat, 16 Jan 2021 10:53:19 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Motif Bio says still no luck in finding a buyer for legacy assets https://www.proactiveinvestors.co.uk/companies/news/915188/motif-bio-says-still-no-luck-in-finding-a-buyer-for-legacy-assets-915188.html Wed, 18 Mar 2020 08:03:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/915188/motif-bio-says-still-no-luck-in-finding-a-buyer-for-legacy-assets-915188.html Motif Bio a step closer to cash shell status after agreement with its main lender https://www.proactiveinvestors.co.uk/companies/news/911635/motif-bio-a-step-closer-to-cash-shell-status-after-agreement-with-its-main-lender-911635.html Tue, 28 Jan 2020 08:42:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/911635/motif-bio-a-step-closer-to-cash-shell-status-after-agreement-with-its-main-lender-911635.html Motif Bio to de-list from Nasdaq in the US https://www.proactiveinvestors.co.uk/companies/news/907828/motif-bio-to-de-list-from-nasdaq-in-the-us-907828.html Tue, 26 Nov 2019 07:14:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/907828/motif-bio-to-de-list-from-nasdaq-in-the-us-907828.html Motif Bio PLC trims board of five directors https://www.proactiveinvestors.co.uk/companies/news/907278/motif-bio-plc-trims-board-of-five-directors-907278.html Mon, 18 Nov 2019 14:19:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/907278/motif-bio-plc-trims-board-of-five-directors-907278.html Motif Bio settles with contract research group https://www.proactiveinvestors.co.uk/companies/news/906708/motif-bio-settles-with-contract-research-group-906708.html Mon, 11 Nov 2019 07:22:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/906708/motif-bio-settles-with-contract-research-group-906708.html Proactive news snapshot: Motif Bio, Midatech Pharma, Vast Resources, Greatland Gold … https://www.proactiveinvestors.co.uk/companies/news/905545/proactive-news-snapshot-motif-bio-midatech-pharma-vast-resources-greatland-gold--905545.html Thu, 24 Oct 2019 14:16:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/905545/proactive-news-snapshot-motif-bio-midatech-pharma-vast-resources-greatland-gold--905545.html Motif Bio says US Defense Department to fund trial of antibiotic iclaprim as aerosol https://www.proactiveinvestors.co.uk/companies/news/905530/motif-bio-says-us-defense-department-to-fund-trial-of-antibiotic-iclaprim-as-aerosol-905530.html Thu, 24 Oct 2019 07:43:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/905530/motif-bio-says-us-defense-department-to-fund-trial-of-antibiotic-iclaprim-as-aerosol-905530.html Motif Bio gets confirmation of requirements for new iclaprim trial https://www.proactiveinvestors.co.uk/companies/news/904556/motif-bio-gets-confirmation-of-requirements-for-new-iclaprim-trial-904556.html Thu, 10 Oct 2019 07:24:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/904556/motif-bio-gets-confirmation-of-requirements-for-new-iclaprim-trial-904556.html Motif Bio raises £600,000 to cover restructuring https://www.proactiveinvestors.co.uk/companies/news/903986/motif-bio-raises-600000-to-cover-restructuring-903986.html Wed, 02 Oct 2019 08:07:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/903986/motif-bio-raises-600000-to-cover-restructuring-903986.html Motif Bio lender supportive ahead of key meeting with American regulator https://www.proactiveinvestors.co.uk/companies/news/901836/motif-bio-lender-supportive-ahead-of-key-meeting-with-american-regulator-901836.html Mon, 02 Sep 2019 06:26:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/901836/motif-bio-lender-supportive-ahead-of-key-meeting-with-american-regulator-901836.html Motif Bio assessing lead drug iclaprim potential as a combatant for the life-threatening infection listeria https://www.proactiveinvestors.co.uk/companies/news/900999/motif-bio-assessing-lead-drug-iclaprim-potential-as-a-combatant-for-the-life-threatening-infection-listeria-900999.html Mon, 19 Aug 2019 06:35:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/900999/motif-bio-assessing-lead-drug-iclaprim-potential-as-a-combatant-for-the-life-threatening-infection-listeria-900999.html Motif Bio's lender postpone's loan amortisation date by one month https://www.proactiveinvestors.co.uk/companies/news/224846/motif-bio-s-lender-postpone-s-loan-amortisation-date-by-one-month-224846.html Thu, 01 Aug 2019 07:40:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/224846/motif-bio-s-lender-postpone-s-loan-amortisation-date-by-one-month-224846.html Motif Bio to meet US regulator on September 19 to discuss trial design https://www.proactiveinvestors.co.uk/companies/news/224551/motif-bio-to-meet-us-regulator-on-september-19-to-discuss-trial-design-224551.html Fri, 26 Jul 2019 06:44:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/224551/motif-bio-to-meet-us-regulator-on-september-19-to-discuss-trial-design-224551.html Motif Bio PLC requests meeting with US regulator to discuss trial design https://www.proactiveinvestors.co.uk/companies/news/223871/motif-bio-plc-requests-meeting-with-us-regulator-to-discuss-trial-design-223871.html Mon, 15 Jul 2019 06:24:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/223871/motif-bio-plc-requests-meeting-with-us-regulator-to-discuss-trial-design-223871.html Motif Bio presents new iclaprim data at industry conference in California https://www.proactiveinvestors.co.uk/companies/news/222643/motif-bio-presents-new-iclaprim-data-at-industry-conference-in-california-222643.html Mon, 24 Jun 2019 06:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/222643/motif-bio-presents-new-iclaprim-data-at-industry-conference-in-california-222643.html Motif Bio says US drugs regulator has encouraged it to carry out further study on antibiotic https://www.proactiveinvestors.co.uk/companies/news/221611/motif-bio-says-us-drugs-regulator-has-encouraged-it-to-carry-out-further-study-on-antibiotic-221611.html Thu, 06 Jun 2019 06:37:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/221611/motif-bio-says-us-drugs-regulator-has-encouraged-it-to-carry-out-further-study-on-antibiotic-221611.html Motif Bio's Graham Lumsden updates on FDA discussions and iclaprim potential https://www.proactiveinvestors.co.uk/companies/news/313472/motif-bio-s-graham-lumsden-updates-on-fda-discussions-and-iclaprim-potential-13472.html Fri, 24 May 2019 07:48:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/313472/motif-bio-s-graham-lumsden-updates-on-fda-discussions-and-iclaprim-potential-13472.html Motif Bio boss “very confident” in potential of flagship antibiotic https://www.proactiveinvestors.co.uk/companies/news/220805/motif-bio-boss-very-confident-in-potential-of-flagship-antibiotic-220805.html Wed, 22 May 2019 14:14:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/220805/motif-bio-boss-very-confident-in-potential-of-flagship-antibiotic-220805.html Motif Bio teams up with German university to see if iclaprim can help patients with rare eye disease https://www.proactiveinvestors.co.uk/companies/news/220750/motif-bio-teams-up-with-german-university-to-see-if-iclaprim-can-help-patients-with-rare-eye-disease-220750.html Wed, 22 May 2019 06:50:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/220750/motif-bio-teams-up-with-german-university-to-see-if-iclaprim-can-help-patients-with-rare-eye-disease-220750.html Motif Bio to present three iclaprim posters at industry conference in San Francisco next month https://www.proactiveinvestors.co.uk/companies/news/220653/motif-bio-to-present-three-iclaprim-posters-at-industry-conference-in-san-francisco-next-month-220653.html Tue, 21 May 2019 06:54:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/220653/motif-bio-to-present-three-iclaprim-posters-at-industry-conference-in-san-francisco-next-month-220653.html Motif Bio meets FDA https://www.proactiveinvestors.co.uk/companies/news/219763/motif-bio-meets-fda-219763.html Tue, 07 May 2019 06:39:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/219763/motif-bio-meets-fda-219763.html Motif Bio partners up with Scottish biotech to develop iclaprim as cystic fibrosis lung infection treatment https://www.proactiveinvestors.co.uk/companies/news/219454/motif-bio-partners-up-with-scottish-biotech-to-develop-iclaprim-as-cystic-fibrosis-lung-infection-treatment-219454.html Wed, 01 May 2019 13:10:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/219454/motif-bio-partners-up-with-scottish-biotech-to-develop-iclaprim-as-cystic-fibrosis-lung-infection-treatment-219454.html Motif Bio higher as it presents data from Phase III iclaprim trial https://www.proactiveinvestors.co.uk/companies/news/218650/motif-bio-higher-as-it-presents-data-from-phase-iii-iclaprim-trial-218650.html Tue, 16 Apr 2019 11:15:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/218650/motif-bio-higher-as-it-presents-data-from-phase-iii-iclaprim-trial-218650.html Motif Bio still hopeful of reaping the benefit from a productive year https://www.proactiveinvestors.co.uk/companies/news/218554/motif-bio-still-hopeful-of-reaping-the-benefit-from-a-productive-year-218554.html Mon, 15 Apr 2019 11:45:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/218554/motif-bio-still-hopeful-of-reaping-the-benefit-from-a-productive-year-218554.html Motif Bio receives vote of confidence as it raises £2.7mln https://www.proactiveinvestors.co.uk/companies/news/217201/motif-bio-receives-vote-of-confidence-as-it-raises-27mln-217201.html Tue, 26 Mar 2019 08:10:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/217201/motif-bio-receives-vote-of-confidence-as-it-raises-27mln-217201.html Motif Bio PLC says it is in the advanced stages of concluding a proposed placing to institutional and other investors https://www.proactiveinvestors.co.uk/companies/news/217110/motif-bio-plc-says-it-is-in-the-advanced-stages-of-concluding-a-proposed-placing-to-institutional-and-other-investors-217110.html Mon, 25 Mar 2019 10:06:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/217110/motif-bio-plc-says-it-is-in-the-advanced-stages-of-concluding-a-proposed-placing-to-institutional-and-other-investors-217110.html Motif Bio surges as US FDA agrees to a meeting to discuss new drug application for novel antibiotic iclaprim https://www.proactiveinvestors.co.uk/companies/news/216830/motif-bio-surges-as-us-fda-agrees-to-a-meeting-to-discuss-new-drug-application-for-novel-antibiotic-iclaprim-216830.html Wed, 20 Mar 2019 11:50:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/216830/motif-bio-surges-as-us-fda-agrees-to-a-meeting-to-discuss-new-drug-application-for-novel-antibiotic-iclaprim-216830.html Motif Bio appoints long-standing board member Bruce Williams as interim chairman, replacing Richard C.E. Morgan https://www.proactiveinvestors.co.uk/companies/news/216618/motif-bio-appoints-long-standing-board-member-bruce-williams-as-interim-chairman-replacing-richard-ce-morgan-216618.html Mon, 18 Mar 2019 08:05:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/216618/motif-bio-appoints-long-standing-board-member-bruce-williams-as-interim-chairman-replacing-richard-ce-morgan-216618.html Motif Bio calls time on iclaprim and to become cash shell https://www.proactiveinvestors.co.uk/companies/news/215068/motif-bio-calls-time-on-iclaprim-and-to-become-cash-shell-215068.html Thu, 21 Feb 2019 09:58:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/215068/motif-bio-calls-time-on-iclaprim-and-to-become-cash-shell-215068.html Motif Bio to manage cash aggressively after making loan repayment https://www.proactiveinvestors.co.uk/companies/news/214781/motif-bio-to-manage-cash-aggressively-after-making-loan-repayment-214781.html Mon, 18 Feb 2019 07:27:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/214781/motif-bio-to-manage-cash-aggressively-after-making-loan-repayment-214781.html